🔎 Trials Near Me

Beranda › Gangguan Depresi Mayor › Illinois › Chicago

Uji klinis Gangguan Depresi Mayor di Chicago, IL

17 studi untuk Gangguan Depresi Mayor mencari peserta di lokasi sekitar Chicago (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder

Menerima pesertaFase 3
  • Charter Research - Chicago, Chicago
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07775300

A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder

Menerima pesertaFase 3
  • Chicago Research Center, Chicago
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07573176

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

Menerima pesertaFase 3
  • Northwestern University, Chicago
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06559306

A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

Menerima pesertaFase 2
  • Chicago Research Center, Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07621237

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

Menerima pesertaFase 3
  • Rush University, Chicago
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06793397

Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder

Menerima pesertaFase 3
  • Vanda Investigational Site, Chicago
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06830044

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

Menerima pesertaFase 2
  • Draig Clinical Site, Chicago
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07610473

Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)

Menerima peserta
  • Rush University Medical Center, Chicago
Usia 22 hingga 70 · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT06423430

A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

Menerima pesertaFase 3
  • Uptown Research Institute, Chicago
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT07592689

A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

Menerima pesertaFase 2
  • EmVenio Research, Chicago
Usia 18 hingga 64 · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT07115329

Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

Menerima pesertaFase 3
  • Clinical Research Site, Chicago
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 24 Jul 2026 · NCT07484217

A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

Menerima pesertaFase 2
  • Flourish Research - Great Lakes Clinical Trials /ID# 278201, Chicago
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 15 Jun 2026 · NCT07276997

Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis

Menerima peserta
  • University of Illinois at Chicago, Chicago
Usia 18 hingga 64 · Semua jenis kelamin · Diperbarui 4 Jun 2026 · NCT05051618

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

Menerima pesertaFase 2
  • Pillar Clinical Research LLC, Chicago
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 11 Mei 2026 · NCT06524830

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

Menerima pesertaStudi observasional
  • University of Chicago Medical Center, Chicago
Usia 18 hingga 40 · Semua jenis kelamin · Diperbarui 10 Mar 2026 · NCT06740383

Study of ALTO-300 in MDD

Menerima pesertaFase 2
  • Site 310, Chicago
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 24 Jul 2025 · NCT05922878

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

Menerima pesertaFase 4
  • Clinical Research Site, Chicago
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 23 Jan 2025 · NCT06223880

Uji klinis Gangguan Depresi Mayor di kota lain

Studi lain di Chicago

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.